XNX-C005D

N/A

Report date: 2025/06/11 11:08:50
NME

Base Information

Drug NameXNX-C005D
Drug Alias Nameonco-parthanatos agent (Xylonix)PARP-1 modulator (Xylonix)C005-DXNX-C005D
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 modulators
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsBreast NeoplasmsCarcinoma, HepatocellularNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXylonix Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXylonix Pte Ltd
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A